Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-029403

Horizon Pharma plc · HZNP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul W. Hoelscher
Officer — EVP, CFO
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 9:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$22.14Mar 23, 2015A276,000A—Mar 22, 2025Ordinary Shares276,000276,000D
Restricted Stock UnitsF2,F3—Mar 23, 2015A124,000A——Ordinary Shares124,000124,000D
Performance Share Units (PSU)F4—Mar 23, 2015A233,000A——Ordinary Shares233,000233,000D

Explanation of responses